Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | PLAGL2 |
| Upstream (Parents) |
|---|
| (<<) CDX2 → PLAGL2 |
| (<<) UBE2C → PLAGL2 |
| (<<) TPX2 → PLAGL2 |
| (<<) MAPRE1 → PLAGL2 |
| Downstream (Children) |
|---|
| PLAGL2 → CEL (>>) |
| PLAGL2 → WIF1 (>>) |
| PLAGL2 → MEP1A (>>) |
| PLAGL2 → CELP (>>) |
| PLAGL2 → LY6G6D (>>) |
| PLAGL2 → EREG (>>) |
| PLAGL2 → NRXN3 (>>) |
| PLAGL2 → OLFM1 (>>) |
| PLAGL2 → MTUS2 (>>) |
| PLAGL2 → VAV3 (>>) |
| PLAGL2 → ACE2 (>>) |
| PLAGL2 → C3orf32 (>>) |
| PLAGL2 → GNG4 (>>) |
| PLAGL2 → SLC26A2 (>>) |
| PLAGL2 → GDPD5 (>>) |
| PLAGL2 → IHH (>>) |
| PLAGL2 → SLC6A4 (>>) |
| PLAGL2 → CYP2W1 (>>) |
| PLAGL2 → TLE2 (>>) |
| PLAGL2 → ATP9A (>>) |
| PLAGL2 → ARID3A (>>) |
| PLAGL2 → DDX27 (>>) |
| PLAGL2 → CPNE1 (>>) |
| PLAGL2 → NEU1 (>>) |
| PLAGL2 → WEE1 (>>) |
